Angioplasty Balloons Market

Global Angioplasty Balloons Market Research By Product Type (Cutting Balloon Catheter, Drug Coated Balloon Catheter, Normal Balloon Catheter and Scoring Balloon Catheter), By Application (Coronary Angioplasty, Peripheral Angioplasty, Carotid Angioplasty, Renal Artery Angioplasty and Venous Angioplasty), and By End User (Hospitals, Ambulatory Surgical Centers and Other) Forecast Period 2021-2027

Published: Jul 2019 | Report Code: OMR2024427 | Category : Medical Devices | Delivery Format: /

The global angioplasty balloons market is growing at a considerable CAGR of 3.2% during the forecast period. The rising pervasiveness of coronary artery diseases is one of the prime factors affecting and driving the market. Increase in the geriatric population along with favorable government policies among others is also estimated to be the key factors that are contributing significantly towards the growth of the market. However, the high cost that is involved in angioplasty and in emerging economies shortfall of reimbursement is the major factors constraints that are hindering the growth of the global angioplasty balloons market across the globe. 

Moreover, growing adoption and demand for minimally invasive surgery in angioplasty balloons is one of the key factors that are creating opportunity for the market. New product launches in the market are likely to drive the growth of the global angioplasty balloons market. For instance, in January 2021, OrbusNeich Medical Co. Ltd. had set forth that it has received acceptance and clearance from the United States Food and Drug Administration (FDA) for JADE 0.014, 0.018 and 0.035. It is considered as an over wire balloon catheter for percutaneous transluminal angioplasty in the peripheral vasculature ranging from 75 cm and 200 cm and its catheter working lengths along with balloon working lengths ranges from 15 mm to 240 mm.

Impact of COVID-19 Pandemic on the Global Angioplasty Balloons Market 

The global angioplasty balloons market is hardly hit by the COVID-19 pandemic since December 2019. The COVID-19 pandemic in the major economies had brought a lot of disruption. Due to COVID-19 pandemic the hospitals were been observed with limited movement of people. Additionally, from a safety point of view, the surgery was also been postponed which has, in turn, affected the adoption of angioplasty balloons by slowing down the growth.

Segmental Outlook 

The market is segmented based on product type, application and end user. Based on product type, the market is segmented into cutting balloon catheter, drug coated balloon catheter, normal balloon catheter and scoring balloon catheter. By application, the market is segmented into coronary angioplasty, peripheral angioplasty, carotid angioplasty, renal artery angioplasty and venous angioplasty. Further, based on end user the market is segmented into hospitals, ambulatory surgical centers and other.

Global Angioplasty Balloons Market Share by Application 2020 (%)

Based on the application, renal artery angioplasty holds a significant share in the market as it is been given across the globe for the effective treatment of patients suffering from a narrowed renal artery. Additionally, renal artery angioplasty with stenting also leads in reducing the chances of congestive heart failure and flash pulmonary edema among people that is supporting the growth of the market.

Regional Outlooks

The global angioplasty balloons market is analyzed based on the geographical regions that are contributing significantly towards the growth of the market. Based on the geography, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America held a considerable share in 2020 in the global angioplasty balloons market. One of the prime factors that are boosting the market growth in North America is rising pervasiveness of cardiovascular disease (CVD) in the region. Additionally, increasing adoption of angioplasty balloons in hospitals for effective treatment along with presence of key market player such as Abbott, Medtronic among others in the region are also driving the growth of the market in the region. 

Global Angioplasty Balloons Market, by Region 2021-2027

Asia-Pacific will have Considerable Growth in the Global Angioplasty Balloons Market

Asia-Pacific region is expected to witness significant growth opportunities for the market. Increasing medical tourism is likely to drive the growth of the regional market. Additionally, favorable policies of government and rising initiatives by the government in this region especially in South Korea, China, and India are supporting the market growth. Further, improving healthcare system and growing pervasiveness of cardiovascular disease (CVD) also some of the factors that are affecting and impacting the growth in this market. 

Market Player Outlook

Key players of the global angioplasty balloons market are Abbott, B. Braun Melsungen AG, Boston Scientific Corp., Koninklijke Philips N.V., and Medtronic. To survive in the market, these players adopt different marketing strategies such as product launches and acquisition. For instance, in November 2020, OrbusNeich Medical Co. Ltd. along with P+F had put forward that it had entered into an agreement for the purpose of minimally invasive heart valve products distribution along with its manufacturing in Asia pacific region such as China, Japan, Taiwan, South Korea, Hong Kong among others.

In September 2020, MEDGYN had done the acquisition of Thomas Medical in order enhance its portfolio in single-use medical devices and accessories.

In July 2020 Terumo Corp. had done the acquisition of one of the Netherlands-based healthcare company named as Quirem Medical B.V., for around $20 million.

In May 2021, Boston Scientific Corp. had commenced first clinical AGENT IDE trial in the US for the Drug-Coated Balloon (DCB) for evaluating the safety along with effectiveness of a DCB in patients.

In September 2019, Terumo Corp. had introduced the R2P MISAGO that will support in treating patients suffering from peripheral artery disease (PAD).

In June 2019, Terumo Corp. had done the strategic partnership with Orchestra BioMed, Inc., for the purpose of getting commercialization rights to Virtue Sirolimus-Eluting Balloon (SEB) for percutaneous coronary that will support in meeting the unmet need in procedure-based medicine.

In October 2019, Koninklijke Philips N.V. had brought out two new balloons to its portfolio of Stellarex 0.035 low-dose drug-coated balloon (DCB).  Both the new balloons that are 200mm and 150mm Stellarex 0.035 had received clearance and approval from the U.S. Food and Drug Administration (FDA) for the treatment of peripheral artery disease (PAD) patients.

The Report Covers

    • Market value data analysis of 2020 and forecast to 2027.

    • Annualized market revenues ($ million) for each market segment.

    • Country-wise analysis of major geographical regions.

    • Key companies operating in the global angioplasty balloons market based on the availability of data, information related to new product launches, and relevant news is also available in the report.

    • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.

    • Analysis of market-entry and market expansion strategies.

    • Competitive strategies by identifying ‘who-stands-where in the market.

    1. Report Summary

    Current Industry Analysis and Growth Potential Outlook

    Impact of COVID-19 on the Global Angioplasty Balloons Industry 

    Recovery Scenario of Global Angioplasty Balloons Industry

    1.1. Research Methods and Tools

    1.2. Market Breakdown

    1.2.1. By Segments

    1.2.2. By Geography

    2. Market Overview and Insights

    2.1. Scope of the Report

    2.2. Analyst Insight & Current Market Trends

    2.2.1. Key Findings

    2.2.2. Recommendations

    2.2.3. Conclusion

    3. Competitive Landscape

    3.1. Key Company Analysis

    3.1.1. Overview  

    3.1.2. Financial Analysis 

    3.1.3. SWOT Analysis

    3.1.4. Recent Developments

    3.2. Key Strategy Analysis

    3.3. Impact of Covid-19 on Key Players

    4. Market Determinants

    4.1. Motivators

    4.2. Restraints

    4.3. Opportunities

    5. Market Segmentation

    5.1. Global Angioplasty Balloons Market by Product Type

    5.1.1. Cutting Balloon Catheter

    5.1.2. Drug Coated Balloon Catheter

    5.1.3. Normal Balloon Catheter

    5.1.4. Scoring Balloon Catheter

    5.2. Global Angioplasty Balloons Market by Application

    5.2.1. Coronary Angioplasty

    5.2.2. Peripheral Angioplasty

    5.2.3. Carotid Angioplasty

    5.2.4. Renal Artery Angioplasty

    5.2.5. Venous Angioplasty

    5.3. Global Angioplasty Balloons Market by End User

    5.3.1. Hospitals

    5.3.2. Ambulatory Surgical Centers

    5.3.3. Other

    6. Regional Analysis

    6.1. North America

    6.1.1. United States

    6.1.2. Canada

    6.2. Europe

    6.2.1. UK

    6.2.2. Germany

    6.2.3. Italy

    6.2.4. Spain

    6.2.5. France

    6.2.6. Rest of Europe 

    6.3. Asia-Pacific

    6.3.1. China

    6.3.2. India

    6.3.3. Japan

    6.3.4. South Korea

    6.3.5. Rest of Asia-Pacific 

    6.4. Rest of the World

    7. Company Profiles 

    7.1. Abbott

    7.2. Avista Capital Partners

    7.3. B. Braun Melsungen AG

    7.4. BIOTRONIK SE & Co KG

    7.5. Boston Scientific Corp.

    7.6. BD (Becton, Dickinson and Company)

    7.7. Cardinal Health

    7.8. ENDOCOR GmbH

    7.9. Koninklijke Philips N.V.

    7.10. Medtronic

    7.11. Merit Medical Systems.

    7.12. MEDGYN

    7.13. Terumo Corp.

    7.14. OrbusNeich Medical Co. Ltd.


    1. GLOBAL ANGIOPLASTY BALLOONS MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)

    2. GLOBAL ANGIOPLASTY BALLOONS MARKET BY PRODUCT TYPE, 2020-2027 ($ MILLION)

    3. GLOBAL CUTTING BALLOON CATHETER MARKET BY REGION, 2020-2027 ($ MILLION)

    4. GLOBAL DRUG COATED BALLOON CATHETER MARKET BY REGION, 2020-2027 ($ MILLION)

    5. GLOBAL NORMAL BALLOON CATHETER MARKET BY REGION, 2020-2027 ($ MILLION)

    6. GLOBAL SCORING BALLOON CATHETER MARKET BY REGION, 2020-2027 ($ MILLION)

    7. GLOBAL ANGIOPLASTY BALLOONS MARKET BY APPLICATION, 2020-2027 ($ MILLION)

    8. GLOBAL CORONARY ANGIOPLASTY MARKET BY REGION, 2020-2027 ($ MILLION)

    9. GLOBAL PERIPHERAL ANGIOPLASTY MARKET BY REGION, 2020-2027 ($ MILLION)

    10. GLOBAL CAROTID ANGIOPLASTY MARKET BY REGION, 2020-2027 ($ MILLION)

    11. GLOBAL RENAL ARTERY ANGIOPLASTY MARKET BY REGION, 2020-2027 ($ MILLION)

    12. GLOBAL VENOUS ANGIOPLASTY MARKET BY REGION, 2020-2027 ($ MILLION)

    13. GLOBAL ANGIOPLASTY BALLOONS MARKET BY END USER, 2020-2027 ($ MILLION)

    14. GLOBAL HOSPITALS MARKET BY REGION, 2020-2027 ($ MILLION)

    15. GLOBAL AMBULATORY SURGICAL CENTERS MARKET BY REGION, 2020-2027 ($ MILLION)

    16. GLOBALOTHER MARKET BY REGION, 2020-2027 ($ MILLION)

    17. GLOBAL ANGIOPLASTY BALLOONS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)

    18. NORTH AMERICAN ANGIOPLASTY BALLOONS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)

    19. NORTH AMERICAN ANGIOPLASTY BALLOONS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)

    20. NORTH AMERICAN ANGIOPLASTY BALLOONS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)

    21. NORTH AMERICAN ANGIOPLASTY BALLOONS MARKET RESEARCH AND ANALYSIS BY END USER, 2020-2027 ($ MILLION)

    22. EUROPEAN ANGIOPLASTY BALLOONS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)

    23. EUROPEAN ANGIOPLASTY BALLOONS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)

    24. EUROPEAN ANGIOPLASTY BALLOONS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)

    25. EUROPEAN ANGIOPLASTY BALLOONS MARKET RESEARCH AND ANALYSIS BY END USER, 2020-2027 ($ MILLION)

    26. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)

    27. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)

    28. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)

    29. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET RESEARCH AND ANALYSIS BY END USER, 2020-2027 ($ MILLION)

    30. REST OF THE WORLD ANGIOPLASTY BALLOONS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)

    31. REST OF THE WORLD ANGIOPLASTY BALLOONS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)

    32. REST OF THE WORLD ANGIOPLASTY BALLOONS MARKET RESEARCH AND ANALYSIS BY END USER, 2020-2027 ($ MILLION)


    1. IMPACT OF COVID-19 ON GLOBAL ANGIOPLASTY BALLOONS MARKET, 2020-2027 ($ MILLION)

    2. IMPACT OF COVID-19 ON GLOBAL ANGIOPLASTY BALLOONS MARKET SHARE BY SEGMENT, 2020-2027 ($ MILLION)

    3. RECOVERY OF GLOBAL ANGIOPLASTY BALLOONS MARKET, 2021-2027 (%)

    4. GLOBAL ANGIOPLASTY BALLOONS MARKET SHARE BY PRODUCT TYPE, 2020 VS 2027 (%)

    5. GLOBAL ANGIOPLASTY BALLOONS MARKET SHARE BY APPLICATION, 2020 VS 2027 (%)

    6. GLOBAL ANGIOPLASTY BALLOONS MARKET SHARE BY END USER, 2020 VS 2027 (%)

    7. GLOBAL ANGIOPLASTY BALLOONS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)

    8. GLOBAL CUTTING BALLOON CATHETER MARKET BY REGION, 2020 VS 2027 (%)

    9. GLOBAL DRUG COATED BALLOON CATHETER MARKET BY REGION, 2020 VS 2027 (%)

    10. GLOBAL NORMAL BALLOON CATHETER MARKET BY REGION, 2020 VS 2027 (%)

    11. GLOBAL SCORING BALLOON CATHETER MARKET BY REGION, 2020 VS 2027 (%)

    12. GLOBAL CORONARY ANGIOPLASTY MARKET BY REGION, 2020 VS 2027 (%)

    13. GLOBAL PERIPHERAL ANGIOPLASTY MARKET BY REGION, 2020 VS 2027 (%)

    14. GLOBAL CAROTID ANGIOPLASTY MARKET BY REGION, 2020 VS 2027 (%)

    15. GLOBAL RENAL ARTERY ANGIOPLASTY MARKET BY REGION, 2020 VS 2027 (%)

    16. GLOBAL VENOUS ANGIOPLASTY MARKET BY REGION, 2020 VS 2027 (%)

    17. GLOBAL HOSPITALS ANGIOPLASTY MARKET BY REGION, 2020 VS 2027 (%)

    18. GLOBAL AMBULATORY SURGICAL CENTERS ANGIOPLASTY MARKET BY REGION, 2020 VS 2027 (%)

    19. GLOBAL OTHER ANGIOPLASTY MARKET BY REGION, 2020 VS 2027 (%)

    20. US ANGIOPLASTY BALLOONS MARKET SIZE, 2020-2027 ($ MILLION)

    21. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, 2020-2027 ($ MILLION)

    22. UK ANGIOPLASTY BALLOONS MARKET SIZE, 2020-2027 ($ MILLION)

    23. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, 2020-2027 ($ MILLION)

    24. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, 2020-2027 ($ MILLION)

    25. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, 2020-2027 ($ MILLION)

    26. SPAIN ANGIOPLASTY BALLOONS MARKET SIZE, 2020-2027 ($ MILLION)

    27. REST OF EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, 2020-2027 ($ MILLION)

    28. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, 2020-2027 ($ MILLION)

    29. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, 2020-2027 ($ MILLION)

    30. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, 2020-2027 ($ MILLION)

    31. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, 2020-2027 ($ MILLION)

    32. REST OF ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, 2020-2027 ($ MILLION)

    33. REST OF THE WORLD ANGIOPLASTY BALLOONS MARKET SIZE, 2020-2027 ($ MILLION)